These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10550848)

  • 1. Relationship between pharmacokinetic parameters of gentamicin and patient characteristics and/or clinical data in patients with solid organ tumours.
    Ortega A; Aldaz A; Giráldez J; Brugarolas A
    Pharm World Sci; 1999 Oct; 21(5):227-32. PubMed ID: 10550848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
    Leader WG; Tsubaki T; Chandler MH
    Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
    Kirkpatrick CM; Duffull SB; Begg EJ
    Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose gentamicin clearance is a predictor of creatinine clearance in spinal man.
    Segal JL; Gilman TA; Thompson JF
    Am J Ther; 2010; 17(4):390-5. PubMed ID: 19531933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "Ideal" Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis.
    Moffett BS; Kam C; Galati M; Schmees L; Stitt GA; Revell PA; Palazzi DL
    Ther Drug Monit; 2018 Jun; 40(3):322-329. PubMed ID: 29521784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of creatinine clearance estimation methods in patients with trauma.
    Davis GA; Chandler MH
    Am J Health Syst Pharm; 1996 May; 53(9):1028-32. PubMed ID: 8744465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram.
    Watling SM; Kisor DF
    Ann Pharmacother; 1993 Feb; 27(2):151-4. PubMed ID: 8439687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of aminoglycoside pharmacokinetics in postpartum patients using Bayesian forecasting.
    Cropp CD; Davis GA; Ensom MH
    Ther Drug Monit; 1998 Feb; 20(1):68-72. PubMed ID: 9485558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin dosing in elderly patients based on bioelectrical impedance analysis.
    Sidhu JS; Triggs EJ; Charles BG; Hickey BP
    Ther Drug Monit; 1994 Aug; 16(4):352-60. PubMed ID: 7974624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
    Staatz CE; Byrne C; Thomson AH
    Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of gentamicin in patients with cancer.
    Rosario MC; Thomson AH; Jodrell DI; Sharp CA; Elliott HL
    Br J Clin Pharmacol; 1998 Sep; 46(3):229-36. PubMed ID: 9764963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of gentamicin. Estimation of initial dosing parameters in hospitalized patients at Al-Amiri Hospital Kuwait.
    Al-Lanqawi Y; Capps P; Abudlmalek K; Al-Anezi K; Thusu A; Sharma P
    Med Princ Pract; 2009; 18(3):209-16. PubMed ID: 19349724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of gentamicin serum concentrations in obstetrics and gynaecology patients in Namibia.
    Singu BS; Mubita M; Thikukutu MM; Mufenda JK; McKenzie SB; Verbeeck RK
    Int J Clin Pharm; 2018 Jun; 40(3):520-525. PubMed ID: 29594677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in comparing treatment outcome from a prospective with that of a retrospective study: assessing the merit of gentamicin therapeutic drug monitoring in pediatric oncology.
    Ho KK; Thiessen JJ; Bryson SM; Greenberg ML; Einarson TR; Leson CL
    Ther Drug Monit; 1994 Jun; 16(3):238-47. PubMed ID: 8085278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic parameters of gentamicin in patients with solid tumors: estimation by one- and two-stage methods.
    Ortega A; Aldaz A; Giráldez J; Brugarolas A
    Ther Drug Monit; 1998 Apr; 20(2):184-90. PubMed ID: 9558133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No role for patient body weight on renal function assessment for drug dosing.
    Ariano RE; Zelenitsky SA; Poncsak KR; Davis JC; Vercaigne LM
    J Antimicrob Chemother; 2017 Jun; 72(6):1802-1811. PubMed ID: 28369383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.